Breaking News Instant updates and real-time market news.

CELG

Celgene

$94.39

2.41 (2.62%)

, BDX

Becton Dickinson

$219.95

4.55 (2.11%)

07:31
02/15/18
02/15
07:31
02/15/18
07:31

Celgene names John Weiland to board of directors

Celgene Corporation (CELG) announced the election of John Weiland to its Board of Directors. Weiland has over 30 years in the healthcare industry and was most recently the President and COO of C. R. Bard, with worldwide responsibility for all of Bard's business operations prior to it being acquired by Becton, Dickinson and Company (BDX) in December 2017.

CELG

Celgene

$94.39

2.41 (2.62%)

BDX

Becton Dickinson

$219.95

4.55 (2.11%)

  • 15

    Feb

  • 16

    Feb

  • 16

    Feb

  • 21

    Feb

  • 25

    Mar

  • 30

    May

CELG Celgene
$94.39

2.41 (2.62%)

02/13/18
02/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/18
LEHM
02/13/18
UPGRADE
Target $105
LEHM
Overweight
Celgene upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Geoff Meacham upgraded Celgene to Overweight with an unchanged price target of $105. The analyst remains concerned about Revlimid concentration risk long-term, but says the current valuation largely reflects the risk. Since the highs in October 2017, the stock has dropped $55 per share, Meacham tells investors in a research note. He notes Celgene's risk/reward profile based on his net present value analysis yields an "attractive upside case."
02/09/18
PIPR
02/09/18
NO CHANGE
PIPR
Piper Jaffray reiterates Outperform on Crispr after CSO departure
Piper Jaffray analyst Edward Tenthoff reiterated an Outperform rating and $39 price target on Crispr Therapeutics, despite Crispr trading down over 13% on news that Dr. Bill Lundberg is stepping down as Chief Scientific Officer and Celgene (CELG) has reduced its stake in the company to 6.1% from 8.0%. Tenthoff said he remains focused on Crispr's "therapeutic opportunity with first-in-man CTX001 Beta thalassemia and potentially sickle cell disease data this year."
01/29/18
WELS
01/29/18
NO CHANGE
Target $23
WELS
Outperform
Iovance Biotherapeutics price target raised to $23 from $17.50 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Iovance Biotherapeutics (IOVA) to $23 following feedback from a "prominent cell therapy expert" late last week. The expert described expanding capacity for Gilead's (GILD) Yescarta, skepticism on Celgene (CELG) and Juno Therapeutics' (JUNO) claims around broad outpatient CAR-T opportunity for JCAR17, and a preference for tumor infiltrating lymphocyte therapeutics from Iovance for solid tumors over T-Cell receptor therapeutics being developed by a large number of companies, Birchenough tells investors in a research note. He reiterates Outperform ratings on both Iovance and Gilead.
BDX Becton Dickinson
$219.95

4.55 (2.11%)

02/06/18
PIPR
02/06/18
NO CHANGE
Target $260
PIPR
Overweight
Becton Dickinson price target raised to $260 from $223 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Becton Dickinson to $260 from $223 following "good" Q1 results and guidance that looks conservative. The analyst believes Becton Dickinson is poised to keep grinding out higher results which in turn will keep the stock moving incrementally higher. He reiterates an Overweight rating on the shares.
01/19/18
01/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Becton Dickinson (BDX) reinstated with a Buy at BofA/Merrill. 2. athenahealth (ATHN) initiated with an In Line at Evercore ISI. 3. Corbus Pharmaceuticals (CRBP) initiated with an Outperform at Raymond James. 4. Trade Desk (TTD) initiated with a Buy at Stifel. 5. Intellipharmaceutics (IPCI) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/19/18
BOFA
01/19/18
INITIATION
Target $260
BOFA
Buy
Becton Dickinson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Bob Hopkins reinstated Becton Dickinson with a Buy and $260 price target saying he sees upside to revenue estimates from CR Bard deal synergies.
01/05/18
01/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Becton Dickinson (BDX) initiated with an Overweight at KeyBanc. 2. Syndax (SNDX) initiated with a Buy at B. Riley FBR. 3. Sutherland Asset Management (SLD) initiated with an Outperform at JMP Securities. 4. Nike (NKE) was assumed with a Buy at Buckingham while Under Armour (UA, UAA) was assumed with a Neutral. 5. Regulus (RGLS) initiated with an Outperform at Leerink. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BBDO

Banco Bradesco

$10.43

(0.00%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Banco Bradesco falls -7.2% »

Banco Bradesco is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$15.27

-1.72 (-10.12%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Intelsat falls -10.1% »

Intelsat is down -10.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$18.96

-3.14 (-14.21%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Guess falls -14.0% »

Guess is down -14.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$3.53

0.245 (7.46%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Crescent Point Energy rises 8.0% »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$25.50

2.595 (11.33%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Conagra Brands rises 11.4% »

Conagra Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CHAP

Chaparral Energy

$5.95

0.64 (12.05%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Chaparral Energy rises 12.2% »

Chaparral Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZBY

Commerzbank

$0.00

(0.00%)

, DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

11:59
03/21/19
03/21
11:59
03/21/19
11:59
Periodicals
Deutsche Bank board discussed Commerzbank merger for 3 hours, Reuters says »

Deutsche Bank's (DB)…

CRZBY

Commerzbank

$0.00

(0.00%)

DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$228.26

-92.21 (-28.77%)

11:53
03/21/19
03/21
11:53
03/21/19
11:53
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

JAZZ

Jazz Pharmaceuticals

$136.47

2.74 (2.05%)

11:50
03/21/19
03/21
11:50
03/21/19
11:50
Recommendations
Jazz Pharmaceuticals analyst commentary  »

Jazz appoval expected but…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
03/21/19
03/21
11:50
03/21/19
11:50
General news
Treasury's $95 B 4- and 8-week bill sales were mixed »

Treasury's $95 B 4-…

EVH

Evolent Health

$13.74

0.585 (4.45%)

11:47
03/21/19
03/21
11:47
03/21/19
11:47
Recommendations
Evolent Health analyst commentary  »

Kentucky Medicaid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$103.54

1.2 (1.17%)

11:45
03/21/19
03/21
11:45
03/21/19
11:45
Options
PayPal call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$37.75

-0.12 (-0.32%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
Conference/Events
Boston Scientific management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

ORHOF

Origin House

$0.00

(0.00%)

, ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
On The Fly
Rising High: An exclusive talk with cannabis brands company Origin House »

In this edition of…

ORHOF

Origin House

$0.00

(0.00%)

ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

APHA

Aphria

$9.98

-0.15 (-1.48%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$20.67

-0.59 (-2.78%)

CGC

Canopy Growth

$45.90

-0.9 (-1.92%)

TLRY

Tilray

$69.93

-0.7 (-0.99%)

IGC

India Globalization Capital

$2.02

0.12 (6.32%)

KNHBF

ICC International Cannabis

$0.00

(0.00%)

ORTFD

Biome Grow

$0.00

(0.00%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

OGRMF

Organigram

$0.00

(0.00%)

KSHB

KushCo Holdings

$0.00

(0.00%)

MMNFF

MedMen

$0.00

(0.00%)

ELLXF

Elixinol Global

$0.00

(0.00%)

PLNHF

Planet 13 Holdings

$0.00

(0.00%)

KHRNF

Khiron Life Sciences

$0.00

(0.00%)

LHSIF

Liberty Health Sciences

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

FB

Facebook

$164.56

-0.91 (-0.55%)

11:37
03/21/19
03/21
11:37
03/21/19
11:37
Hot Stocks
Facebook says issues fixed after finding user passwords readable by employees »

Facebook's VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

11:36
03/21/19
03/21
11:36
03/21/19
11:36
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:36
03/21/19
03/21
11:36
03/21/19
11:36
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:35
03/21/19
03/21
11:35
03/21/19
11:35
General news
U.S. equities have ramped higher »

U.S. equities have ramped…

SRC

Spirit Realty

$37.60

0.54 (1.46%)

11:31
03/21/19
03/21
11:31
03/21/19
11:31
Conference/Events
Spirit Realty management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 09

    May

WFC

Wells Fargo

$49.32

-1.07 (-2.12%)

, GS

Goldman Sachs

$193.30

-0.97 (-0.50%)

11:27
03/21/19
03/21
11:27
03/21/19
11:27
Periodicals
Wells Fargo in talks to hire former Goldman co-COO as its CEO, NY Post reports »

Wells Fargo (WFC) is in…

WFC

Wells Fargo

$49.32

-1.07 (-2.12%)

GS

Goldman Sachs

$193.30

-0.97 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 23

    Apr

  • 28

    May

  • 13

    Jul

  • 12

    Oct

FB

Facebook

$165.28

-0.19 (-0.11%)

11:26
03/21/19
03/21
11:26
03/21/19
11:26
Periodicals
Facebook stored user passwords in plain text for years, KrebsOnSecurity says »

Hundreds of millions of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

WDC

Western Digital

$50.60

3.43 (7.27%)

11:25
03/21/19
03/21
11:25
03/21/19
11:25
Options
Western Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:25
03/21/19
03/21
11:25
03/21/19
11:25
General news
Treasury Action: the yield curve is a big topic of conversation »

Treasury Action: the…

11:25
03/21/19
03/21
11:25
03/21/19
11:25
Conference/Events
JPMorgan medtech analyst to hold a group luncheon »

Medtech Analyst Marcus…

PEB

Pebblebrook Hotel

$32.07

0.34 (1.07%)

11:21
03/21/19
03/21
11:21
03/21/19
11:21
Conference/Events
Pebblebrook Hotel management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 28

    Mar

  • 29

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.